Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
Submitted by
admin
on November 18, 2011 - 11:39am
Source:
Motley Fool
News Tags:
EMA
AstraZeneca
medullary thyroid cancer
vandetanib
Headline:
AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
Do Not Allow Advertisers to Use My Personal information
